The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,543
Sort by:
Orphan Drug Commercialisation and Market Access in Emerging Markets
US$ 695.00
Market access for orphan drugs: Can your company break through in emerging markets? Find out which emerging markets offer the best investment prospects for orphan drug ... America Market Access Director, Leading Orphan Drug Company International Marketing Director, Europe-based orphan drug manufacturer Market Access Director, Rare Cancers-focused Biopharmaceutical Company Orphan Disease ...
June 2016
The Cost of Specialty Drugs: Payer perspectives
US$ 2,195.00
... strategy and build a more compelling case for specialty drugs with FirstWord’s new report, The Cost of Specialty Drugs: Payer Perspectives. Click here to view the ... in approaches to managing specialty drug costs and the challenges faced by payers today. Read it to understand how the market is responding to rapidly rising specialty drug costs – and assess ...
June 2016
Drugs of Abuse: France, Germany, Italy, Spain, UK-Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
US$ 5,200.00
... report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...
June 2016
300 pages
Drugs of Abuse: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
US$ 5,200.00
This new 300-page report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
June 2016
300 pages
Global Omega-3 PUFA Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Omega-3 PUFA Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Omega-3 PUFA industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Omega-3 PUFA industry; 3.) the North American Omega-3 PUFA industry; 4.) the European Omega-3 PUFA industry; 5.) market entry and investment feasibility ...
June 2016
152 pages
Drug Discovery Informatics Market Size & ForecastByWorkflow,(Discovery Informatics, Development Informatics, Identification & Validation Informatics Assay Development Informatics, Lead Generation Informatics, Lead Optimization, FHD Preparation, Phase IA Informatics, &Phase IB/2 Informatics), By Mode,(In-house Informatics, Outsourced Informatics), By Services,(Sequence Analysis Platforms, Molecular Modeling, Docking, &Clinical Trial Data Management), And Trend Analysis From 2012 To 2022
US$ 4,450.00
Global drug discovery informatics market is anticipated to reach USD 6,548.1 million by 2022, according to a new ... drive the adoption of in-silicotherapeutic product discovery models thus, influencing sectorprogress over the forecast period. Drug discovery informatics industry is estimated to witness lucrative ...
June 2016
78 pages
Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition
US$ 800.00
... is no way the body can produce iron itself. Intravenous (IV) treatment, in a broad sense, ... the first generation drugs InFed (iron dextran) and Dexeferrum (iron dextra) and feraccru ... global iron products industry along with an extensive coverage of global, Europe and the US I.V. iron market. The global IV iron ...
May 2016
51 pages
Financial Assessment and Credit Risk Analysis of Veterinary Drug Industry in China 2016
US$ 5,500.00
... made. 1.INTRODUCTION In this report, ASKCI analyzes the financial assessment and credit risk of veterinary drug industry. It will provide you ... understanding of financial situation and credit risk on China’s veterinary drug industry; To understand position of the veterinary drug industry in China; To get more ...
May 2016
50 pages
Obesity Drugs and Therapies: Technologies and Global Markets
US$ 1,375.00
... market for obesity treatments should reach more than $7.8 billion by 2021 from over $4.3 billion in 2016 increasing at a compound annual growth rate ... surgeries market should reach over $4.3 billion by 2021 from almost $3.4 billion in 2016, at a CAGR of 5.0% from 2016 to 2021. The FDA-approved drugs market ...
May 2016
176 pages
Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021
US$ 1,190.00
... from 7 viewpoints: 1. Renal Cell Carcinoma (RCC) - Disease Overview 2. Renal Cell Carcinoma (RCC) - Epidemiology 3. Global Renal Cell Carcinoma - Diagnosed Incident Cases to 2023 (8 Countries Covered) 4. Global Renal Cell Carcinoma - Five-Year Diagnosed ... (11 Brands Covered) 6. Global Renal Cell Carcinoma Drugs - Pipeline Analysis (18 Drugs Covered) 7. Global Renal Cell Carcinoma Drugs – Market Drivers and Restraints Global Renal Cell Carcinoma - Diagnosed Incident Cases ...
May 2016
148 pages
Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics andRevenue Forecasts to 2022, NAIC 325411
US$ 1,995.00
Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, ... countless hours of research. Key Findings: Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $22.2 billion by 2022. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry ...
May 2016
68 pages
Global Malignant Melanoma Drug Market & Clinical Pipeline Insight
US$ 2,400.00
... Global Malignant Melanoma Drug Market & Clinical Pipeline Insight” Report Highlight: Global Malignant Melanoma Market Analysis Malignant Melanoma Drug Mechanism of Action Global Malignant Melanoma Clinical Pipeline By Company & Phase Global Malignant Melanoma Clinical Pipeline: 201 Drugs Majority Malignant ...
May 2016
500 pages
Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020)
US$ 800.00
... “Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along ... . The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc. Further, key players of the injectable drug market such as Merck ...
April 2016
57 pages
Orphan Drug Commercial Models: Sustaining the rare disease business
US$ 695.00
... a part, so which model is best and what are the considerations which underpin that choice? This report analyses current orphan drug commercial models, assesses their ... for orphan drugs commercial teams to ensure that their business model works for all stakeholders? Key components: What are the key components of current commercial models ...
April 2016
Global Cervical Cancer Treatment Drugs Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Cervical Cancer Treatment Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cervical Cancer Treatment Drugs industry, focusing on the ... with: 1.) basic information; 2.) the Asia Cervical Cancer Treatment Drugs industry; 3.) the North American Cervical Cancer Treatment Drugs industry; 4.) the European Cervical Cancer Treatment Drugs industry; 5.) market entry and investment feasibility ...
April 2016
158 pages
Global Asthma Treatment Drugs Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Asthma Treatment Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Asthma Treatment Drugs industry, focusing on the ... with: 1.) basic information; 2.) the Asia Asthma Treatment Drugs industry; 3.) the North American Asthma Treatment Drugs industry; 4.) the European Asthma Treatment Drugs industry; 5.) market entry and investment feasibility ...
April 2016
158 pages
Global Drug Testing Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Drug Testing Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Drug Testing industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Drug Testing industry; 3.) the North American Drug Testing industry; 4.) the European Drug Testing industry; 5.) market entry and investment feasibility ...
April 2016
158 pages
Global Leukemia Treatment Drugs Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Leukemia Treatment Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Leukemia Treatment Drugs industry, focusing on the ... with: 1.) basic information; 2.) the Asia Leukemia Treatment Drugs industry; 3.) the North American Leukemia Treatment Drugs industry; 4.) the European Leukemia Treatment Drugs industry; 5.) market entry and investment feasibility ...
April 2016
158 pages
Global Pain and Fever Relief Drugs Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Pain and Fever Relief Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Pain and Fever Relief ... information; 2.) the Asia Pain and Fever Relief Drugs industry; 3.) the North American Pain and Fever Relief Drugs industry; 4.) the European Pain and Fever Relief Drugs industry; 5.) market ...
April 2016
158 pages
Global General Anesthesia Drugs Industry 2016 Market Research Report
US$ 2,850.00
2016 Global General Anesthesia Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the General Anesthesia Drugs industry, focusing on the ... with: 1.) basic information; 2.) the Asia General Anesthesia Drugs industry; 3.) the North American General Anesthesia Drugs industry; 4.) the European General Anesthesia Drugs industry; 5.) market entry and investment feasibility ...
April 2016
159 pages
Global Antibiotics Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Antibiotics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Antibiotics industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Antibiotics industry; 3.) the North American Antibiotics industry; 4.) the European Antibiotics industry; 5.) market entry and investment feasibility; and ...
April 2016
159 pages
Global Immunotherapy Drugs Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Immunotherapy Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Immunotherapy Drugs industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Immunotherapy Drugs industry; 3.) the North American Immunotherapy Drugs industry; 4.) the European Immunotherapy Drugs industry; 5.) market entry and investment feasibility ...
April 2016
159 pages
Global Therapeutic Drug Monitoring (TDM) Industry 2016 Market Research Report
US$ 2,850.00
2016 Global Therapeutic Drug Monitoring (TDM) Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Therapeutic Drug Monitoring (TDM) industry, focusing on the ... with: 1.) basic information; 2.) the Asia Therapeutic Drug Monitoring (TDM) industry; 3.) the North American Therapeutic Drug Monitoring (TDM) industry; 4.) the European Therapeutic Drug Monitoring (TDM) industry; 5.) market entry and investment feasibility ...
April 2016
159 pages
Japan Generics Drug Market Outlook 2020
US$ 1,500.00
... Japan Generics Drug Market Outlook 2020” Report Highlights: Introduction to Japanese Generic Drug Market Attractiveness of Japanese Generic Market Super Generics in Japan Japan Healthcare System & Generic Drugs Different Parameters for Generic & Branded Drugs Comparison of Generic Drugs in US & Japan Japan ...
April 2016
66 pages
Analysis China Vitamin B1 Monthly Export Monitoring
US$ 2,230.00
... China Vitamin B1 Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin B12 Monthly Export Monitoring
US$ 2,230.00
... China Vitamin B12 Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin B2 Monthly Export Monitoring
US$ 2,230.00
... China Vitamin B2 Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin B6 Monthly Export Monitoring
US$ 2,230.00
... China Vitamin B6 Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin B8 Monthly Export Monitoring
US$ 2,230.00
... China Vitamin B8 Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin D2 Monthly Export Monitoring
US$ 2,230.00
... China Vitamin D2 Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin D3 Monthly Export Monitoring
US$ 2,230.00
... China Vitamin D3 Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin E Monthly Export Monitoring
US$ 2,230.00
... China Vitamin E Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin K Monthly Export Monitoring
US$ 2,230.00
... China Vitamin K Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Analysis China Vitamin K2 Monthly Export Monitoring
US$ 2,230.00
... China Vitamin K2 Monthly Export Monitoring' The analysis is based on the original complete China Customs transaction records, we conduct a series of research & analysis to locate the target commodity’s transaction ... & the export specifications. From our analysis you can see that we use 4 sheets to present our analysis & comparison from different dimensions to help ...
March 2016
Pay-for-Performance and Drug Pricing: Impact and Response of Pharma [2016]
US$ 695.00
... , what can Pharma do to ensure positive payer support for its pricing proposals? Pay-for-Performance and Drug Pricing Pressure: Impact and Response from Pharma intensively examines the ... setting the pay-for-performance vs pricing status quo agenda Understand how public payers are reforming health delivery and assess the likely impact on pharma ...
February 2016
Investigation Report on China Fluoxetine Market, 2010-2019
US$ 2,000.00
... first in Belgium in 1986. Fluoxetine is a kind of selective serotonin reuptake inhibitors (SSRI) antidepressants and its medicinal form is Fluoxetine hydrochloride. Eli Lilly and ... number of Fluoxetine drugs on the market. There is a broad demand market of Fluoxetine in China. From 2010 to 2014, according to CRI’s survey on sample hospitals, CAGR of Fluoxetine is up to 9.68%. Eli ...
February 2016
20 pages
Investigation Report on China Methylcobalamin Market, 2010-2019
US$ 2,000.00
... more information: Market scale of Methylcobalamin in China Market Competitive pattern of Methylcobalamin in China Sales price of Methylcobalamin made by different enterprises in China Market outlook of Methylcobalamin in China The author recommends the following people to purchase this report: Production enterprises of methylcobalamin ...
February 2016
20 pages
US Generic Drug Market Opportunity Outlook 2020
US$ 1,500.00
... Generic Drugs Supportive Features of US Generic Drug Laws Effect of Generic Drug Import on US Economy Methods to Achieve Higher Cost Arbitrage by Generic Drugs Role of Online Pharmacies in Expansion of US Generic Drugs Market US Generic Drugs Market ...
February 2016
100 pages
Global Renal Cell Carcinoma Drugs Market 2020
US$ 1,500.00
... more drugs in various phases of clinical trials, which will help in the growth of this market. According to the report “Global Renal Cell Carcinoma Drugs Market 2020”, the renal cell carcinoma drugs market is anticipated to cross US$ 4 Billion by 2020. The report provides a detailed analysis of the market for these drugs. The ...
January 2016
65 pages
Innovations in Drug Pricing and Reimbursement (2016)
US$ 2,195.00
... friends when it comes to drug pricing. Public, health professional, political and payer hostility is growing worldwide as the prices of new drugs for chronic disease, specialty ... of justifying high drug prices to fund innovation and development need an overhaul? Risk Sharing: Are risk-sharing, value-based pricing and pricing by indication the best ...
January 2016
